Tag: Icosavax
AstraZeneca: Successfully completes the acquisition of Icosavax
(CercleFinance.com) – AstraZeneca announced today that it has successfully completed the acquisition of Icosavax, an American biopharmaceutical company focused on the development of ‘high-potential differentiated vaccines’. Following this acquisition, Icosavax…
AstraZeneca buys American biotech Icosavax, vaccine specialist
(AOF) – AstraZeneca today announced the successful completion of the acquisition of Icosavax, a US clinical-stage biopharmaceutical company focused on the development of high-potential differentiated vaccines using an innovative virus-like…
AstraZeneca buys respiratory vaccine developer Icosavax for $1.1 billion – 12/12/2023 at 11:08 a.m.
(Added quote from interview in paragraph 5, actions of Icosavax in paragraph 3, history and context throughout) by Yadarisa Shabong AstraZeneca AZN.L said on Tuesday it had agreed to buy…